Kreis H - Search Results

1

Functional analysis of lymphocytes recovered from human allograft undergoing rejection.

Caillat S, Poisson J, Campos H, Debure A, Kreis H, Bach JF, Chatenoud L. Caillat S, et al. Among authors: kreis h. Transplant Proc. 1987 Feb;19(1 Pt 1):389-91. Transplant Proc. 1987. PMID: 3274790 No abstract available.

2

Prediction of successful allograft rejection retreatment with OKT3.

Legendre C, Kreis H, Bach JF, Chatenoud L. Legendre C, et al. Among authors: kreis h. Transplantation. 1992 Jan;53(1):87-90. doi: 10.1097/00007890-199201000-00016. Transplantation. 1992. PMID: 1733090 Clinical Trial.

3

Differential in situ expression of cytokine genes in human renal rejection.

Caillat-Zucman S, Vanden Broecke C, Legendre C, Noel LH, Kreis H, Bach JF, Tovey MG. Caillat-Zucman S, et al. Among authors: kreis h. Transplant Proc. 1991 Feb;23(1 Pt 1):229-30. Transplant Proc. 1991. PMID: 1899302 No abstract available.

4

Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome--dosage and kinetics prerequisites.

Chatenoud L, Legendre C, Ferran C, Bach JF, Kreis H. Chatenoud L, et al. Among authors: kreis h. Transplantation. 1991 Feb;51(2):334-8. doi: 10.1097/00007890-199102000-00012. Transplantation. 1991. PMID: 1899732 Clinical Trial.

5

In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids.

Chatenoud L, Ferran C, Legendre C, Thouard I, Merite S, Reuter A, Gevaert Y, Kreis H, Franchimont P, Bach JF. Chatenoud L, et al. Among authors: kreis h. Transplantation. 1990 Apr;49(4):697-702. doi: 10.1097/00007890-199004000-00009. Transplantation. 1990. PMID: 2109379

6

Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.

Chatenoud L, Ferran C, Legendre C, Kurrle R, Kreis H, Bach JF. Chatenoud L, et al. Among authors: kreis h. Transplant Proc. 1990 Aug;22(4):1787-8. Transplant Proc. 1990. PMID: 2117809 No abstract available.

7

The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells.

Caillat-Zucman S, Blumenfeld N, Legendre C, Noel LH, Bach JF, Kreis H, Chatenoud L. Caillat-Zucman S, et al. Among authors: kreis h. Transplantation. 1990 Jan;49(1):156-60. Transplantation. 1990. PMID: 2137271

8

In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.

Caillat-Zucman S, Legendre C, Noel LH, Bach JF, Kreis H, Chatenoud L. Caillat-Zucman S, et al. Among authors: kreis h. Transplant Proc. 1990 Aug;22(4):1782. Transplant Proc. 1990. PMID: 2143860 No abstract available.

9

A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection.

Kreis H, Chkoff N, Chatenoud L, Debure A, Lacombe M, Chrétien Y, Legendre C, Caillat S, Bach JF. Kreis H, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1741-4. Transplant Proc. 1989. PMID: 2652570 Clinical Trial. No abstract available.

10

Cytomegalovirus infection in fifty-two renal transplant recipients.

Godeaut E, Galezowski N, Berche P, Bonissol C, Debure A, Kreis H. Godeaut E, et al. Among authors: kreis h. Transplant Proc. 1987 Feb;19(1 Pt 3):2131-2. Transplant Proc. 1987. PMID: 2856277 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters